Market closedNon-fractional
Amneal Pharmaceuticals/AMRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Amneal Pharmaceuticals
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Ticker
AMRX
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Bridgewater, United States
Employees
7,850
Website
amneal.com
AMRX Metrics
BasicAdvanced
$2.3B
Market cap
-
P/E ratio
-$0.79
EPS
1.33
Beta
-
Dividend rate
Price and volume
Market cap
$2.3B
Beta
1.33
Financial strength
Current ratio
1.654
Quick ratio
0.859
Long term debt to equity
-15,157.247
Total debt to equity
-16,534.166
Interest coverage (TTM)
1.40%
Management effectiveness
Return on assets (TTM)
5.45%
Return on equity (TTM)
-165.27%
Valuation
Price to revenue (TTM)
0.638
Price to book
-35.74
Price to tangible book (TTM)
-1.49
Price to free cash flow (TTM)
12.819
Growth
Revenue change (TTM)
9.82%
Earnings per share change (TTM)
-11.87%
3-year revenue growth (CAGR)
7.89%
3-year earnings per share growth (CAGR)
84.43%
What the Analysts think about AMRX
Analyst Ratings
Majority rating from 6 analysts.
AMRX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$659M
6.84%
Net income
-$92M
-7.10%
Profit margin
-13.89%
-13.08%
AMRX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.19
$0.19
$0.14
$0.14
-
Expected
$0.11
$0.13
$0.09
$0.09
$0.14
Surprise
79.25%
49.84%
55.21%
52.17%
-
AMRX News
AllArticlesVideos
![Amneal Pharmaceuticals: Maintaining Momentum Is Key To Success](/_next/image?url=https%3A%2F%2Fcdn.snapi.dev%2Fimages%2Fv1%2Fu%2Fn%2Fdrugs30-2517733.jpg&w=3840&q=75)
Amneal Pharmaceuticals: Maintaining Momentum Is Key To Success
Seeking Alpha·2 weeks ago
![Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies](/_next/image?url=https%3A%2F%2Fcdn.snapi.dev%2Fimages%2Fv1%2Fv%2Fb%2Fpress15-2463442.jpg&w=3840&q=75)
Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies
Business Wire·2 months ago
![Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California](/_next/image?url=https%3A%2F%2Fcdn.snapi.dev%2Fimages%2Fv1%2Fv%2Fe%2Fpress10-2444322.jpg&w=3840&q=75)
Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Amneal Pharmaceuticals stock?
Amneal Pharmaceuticals (AMRX) has a market cap of $2.3B as of July 25, 2024.
What is the P/E ratio for Amneal Pharmaceuticals stock?
The price to earnings (P/E) ratio for Amneal Pharmaceuticals (AMRX) stock is 0 as of July 25, 2024.
Does Amneal Pharmaceuticals stock pay dividends?
No, Amneal Pharmaceuticals (AMRX) stock does not pay dividends to its shareholders as of July 25, 2024.
When is the next Amneal Pharmaceuticals dividend payment date?
Amneal Pharmaceuticals (AMRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Amneal Pharmaceuticals?
Amneal Pharmaceuticals (AMRX) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
![Buy or sell Amneal Pharmaceuticals stock](/_next/image?url=%2Fresources%2Fimages%2Fpromo_phone.png&w=256&q=75)
Buy or sell Amneal Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.